Dormikum

Roman name

Dormicum

The composition and the form of

1 tablet contains midazolama maleate 15 mg; blistere in 10 pcs. , in box 1, 2, 3 or 10 blisterov.1 ml solution for injection contains midazolama hydrochloride 5 mg; 182,000,000 in the 1 and 3 ml, in a box of 10 and 25 pc. respectively.

Farmakodinamika

Quick offensive sleep, increasing its length to the inherent age rule does not affect the phase of rapid sleep.

Indications

Stage before diagnostic or therapeutic procedures premedikation, the introduction of anaesthesia and maintenance narcosis (including children), ataralgesia (in combination with ketaminom), insomnia (Table).

Pregnancy and lactation

Contraindicated in the first trimester of pregnancy and breast-feeding.

Side-Effects

The AD aetiology, re 5a8 spiratory depression, patients, cause respiratory and / or cardiac arrest, nausea, vomiting, headache, icota, laringospazm, dizziness, hallucinations, overweight sedative effect, drowsiness, ataxy, anterogradnaya amnesia, pain and throm in the introduction, convulsions (at the premature and newborn children), allergic reaction (from the skin to anaphylactoidnykh). After a lengthy in / in the sudden cancellation preparation may be accompanied by withdrawal symptoms.

Patient interaction

Do deprimiruty effect antipsihotikov, sleeping, anxiety, antidepressants, narcotic analgesics, alcohol, anaesthetics protivosudorozhnykh, sedatives and antigistaminnah funds. Monooksigenazna suppression of the liver (zimetidin) lengthens the sedative effect.

Storage conditions

In the dark place at a temperature of no higher than 30 ° C

Shelf life

3 years

The registration

012619/02-2001

Directory → Neurotropic funds → Hypnotics funds → Dormikum